Diagnostic Evaluation of Pulmonary Embolism During the COVID-19 Pandemic
Lionel S. Zuckier, Renée M. Moadel, Linda B. Haramati, Leonărd M. Freeman
Abstract
The rapid emergence of the COVID-19 pandemic has altered the risk–benefit calculus of many activities, including the practice of medicine. COVID-19 is caused by a single-strand RNA virus, SARS-CoV-2, belonging to the Coronaviridae family. The virus is known to infect the upper respiratory tract
Topics & Concepts
CoronaviridaePandemicCoronavirus disease 2019 (COVID-19)VirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineVirusCoronavirusPathologyInfectious disease (medical specialty)DiseaseVenous Thromboembolism Diagnosis and ManagementCOVID-19 and healthcare impactsCOVID-19 Clinical Research Studies